| INSR antibodies | | | This is a review about insulin receptor antibodies, based on 18 published articles using insulin receptor antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited insulin receptor antibody. |
| Cell Signaling Technology search Cell Signaling Technology INSR products | | wb | Cell Signaling Technology IR antibody was used in western blot to study the association of glucose-6-phosphate dehydrogenase overexpression with lipid dysregulation and insulin resistance in obesity. to the paper | | wb | Cell Signaling Technology anti-phospho-IR antibody was used in western blot to show that Annexin-II was bound to insulin and insulin-like growth factor-1 (IGF-1) receptors in PC12 cells and NIH-3T3 cells. to the paper |
| Santa Cruz Biotechnology search Santa Cruz Biotechnology INSR products | | wb | Santa Cruz Biotechnology anti-insulin receptor SC-711 antibody was used in western blot and immunoprecipitation to identify LRIG1 as a novel negative regulator of the Met receptor and its role on opposing Met and Her2 synergy. to the paper | | ip | The liver, hindlimb muscle and epididymal fat tissue were removed 300 s later and the homogenates were used for immunoprecipitation with anti-IR (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-IRS-1 (7) or anti-IRS-2 antibody (Cell Signaling Technology, Beverly, MA, USA). to the paper | | ih, wb | Santa Cruz anti-ß-subunit of InsR antibody was used in paraffin sections and protein from mouse, and which were respectively used in immunohistohistochemistry and western blot, to study the relationship between severely impaired insulin signaling and chronic wounds of diabetic ob/ob mice. to the paper | | wb | Santa Cruz Biotechnology anti-Insr beta subunit antibody(C-19) was used in western blot to study the contribution of Insr signaling in extrahepatic tissues to the control of hepatic glucose fluxes in Insr knockout mice. to the paper | | ip | Santa Cruz Biotechnology rabbit polyclonal anti-IR {beta}-subunit receptor antibody (C-19) was used in immunoprecipitation to study the expression level of insulin-like growth factor I receptors and insulin receptors in human micro- and macrovascular endothelial cells. to the paper | | ip, wb | Santa Cruz Biotechnology anti-IR alpha antibody was used in western blot and immunoprecipitation to identify two substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. to the paper | | ip | Santa Cruz Biotechnology IR antibody was used in immunoprecipitation to show that Annexin-II was bound to insulin and insulin-like growth factor-1 (IGF-1) receptors in PC12 cells and NIH-3T3 cells. to the paper | | ic | Santa Cruz Biotechnology polyclonal INSR antibody 29B4 (which recognizes the IR beta-subunit) was used in immunocytochemistry to study the biological characteristics of insulin/insulin-like growth factor I hybrid receptors. to the paper | | ip, wb | Santa Cruz Biotechnology polyclonal anti-IR antibody was used in COS cells (which were ransfected with plasmids encoding HA-RACK1) and in immunoprecipitation, western blot to study the role for the interaction between RACK1 and insulin-like growth factor 1 (IGF-1) receptor in regulating IGF-1-mediated Akt activation and protection from cell death. to the paper | | wb | Santa Cruz Biotechnology IR beta-subunit polyclonal antibody was used in western blot to study insulin receptor catalytic activity inhibition. to the paper | | wb | Santa Cruz Biotechnology polyclonal antibody against the insulin receptor beta-subunit was used in western blot to study the mitogenic action of insulin regulated by Shc and CEACAM1 interaction. to the paper | | wb | Santa Cruz Biotechnology anti-insulin receptor-beta antibody (C-19) was used in western blot to study the interaction between a PDZ domain protein and the c-terminal tail of the insulin-like growth factor-1. to the paper |
| Invitrogen search Invitrogen INSR products | | ip, wb | BIOSOURCE phosphospecific Tyr-1162/1163 IR antibody was used in western blot and immunoprecipitation to show that the liver is a major site of the peripheral action of PTP1B in regulating glucose homeostasis. to the paper |
| BD Biosciences search BD Biosciences INSR products | | wb | BD Transduction Insulin Receptor b antibody was tested in western blot by Abminer . to the paper | | ip, wb | Transduction Laboratories anti-IR antibody was used in western blot and immunoprecipitation to detect IR in CHO cell expressing the IR and IRS-1 transfected with MOR. to the paper | | wb | Transduction Laboratories rabbit polyclonal antibody that recognizes the IR beta-subunit was used in western blot to study the biological characteristics of insulin/insulin-like growth factor I hybrid receptors. to the paper |
| Millipore search Millipore INSR products | | ip, wb | Upstate Biotechnology anti-IRS-1 antibody was used in western blot and immunoprecipitation to study interleukin-6-dependent insulin resistance in hepatocytes by suppressor of cytokine signaling-3 (SOCS-3). to the paper | | ip | Upstate Biotechnologies polyclonal anti-beta subunit of insulin receptor (betaIR) antibody was used in human hepatoma (HepG2) calls and in immunoprecipitation to study the effect of the increasing of free, unbound insulin-like growth factor I on insulin responsiveness in human hepatoma G2 cells in culture. to the paper |
| DRS. C. R. KAHN (JOSLIN DIABETES CENTER) | | ip, wb | Drs. C. R. Kahn (Joslin Diabetes Center)IR antibody was used in western blot and immunoprecipitation to show that the liver is a major site of the peripheral action of PTP1B in regulating glucose homeostasis. to the paper |
| NEOMARKER | | ip | NeoMarker monoclonal anti-alpha subunit of insulin receptor (alphaIR) antibody (47-9 and 83-14) was used in human hepatoma (HepG2) calls and in immunoprecipitation to study the effect of the increasing of free, unbound insulin-like growth factor I on insulin responsiveness in human hepatoma G2 cells in culture. to the paper |
| Articles Reviewed | | 1: | David L Shattuck et al. LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy. 2007 | | 2: | Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 | | 3: | Kenji Uno et al. Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. 2006 | | 4: | Itamar Goren et al. Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alpha. 2006 | | 5: | Fawaz G Haj et al. Liver-specific protein-tyrosine phosphatase 1B (PTP1B) re-expression alters glucose homeostasis of PTP1B-/-mice. 2005 | | 6: | Haruka Okamoto et al. Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. 2005 | | 7: | Jiyoung Park et al. Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity. 2005 | | 8: | Simona I Chisalita et al. Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells. 2004 | | 9: | Wei-Qin Zhao et al. Secretion of Annexin II via activation of insulin receptor and insulin-like growth factor receptor. 2003 | | 10: | Yu Li et al. Morphine induces desensitization of insulin receptor signaling. 2003 | | 11: | Joseph J Senn et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. 2003 | | 12: | Dongsheng Cai et al. Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. 2003 | | 13: | Giuseppe Pandini et al. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. 2002 | | 14: | Matthew N Poy et al. Shc and CEACAM1 interact to regulate the mitogenic action of insulin. 2002 | | 15: | Veronique Béréziat et al. Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14. 2002 | | 16: | Patrick A Kiely et al. RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death. 2002 | | 17: | Keiji Sakai et al. Increases in free, unbound insulin-like growth factor I enhance insulin responsiveness in human hepatoma G2 cells in culture. 2002 | | 18: | T Ligensa et al. A PDZ domain protein interacts with the C-terminal tail of the insulin-like growth factor-1 receptor but not with the insulin receptor. 2001 |
|